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Antibody molecules are able to recognize any antigen with high affinity and specificity. To get insight into the
molecular diversity at the source of this functional diversity, we compiled and analyzed a non-redundant aligned
collection of 227 structures of antibody–antigen complexes. Free energy of binding of all the residue side chains
was quantified by computational alanine scanning, allowing the first large-scale quantitative description of
antibody paratopes. This demonstrated that as few as 8 residues among 30 key positions are sufficient to explain
80% of the binding free energy inmost complexes. At these positions, the residue distribution is not only different
from that of other surface residues but also dependent on the role played by the side chain in the interaction,
residues participating in the binding energy being mainly aromatic residues, and Gly or Ser otherwise. To
question the generality of these binding characteristics, we isolated an antibody fragment by phage display using
a biased synthetic repertoire with only two diversified complementarity-determining regions and solved its
structure in complex with its antigen. Despite this restricted diversity, the structure demonstrated that all
complementarity-determining regions were involved in the interaction with the antigen and that the rules derived
from the natural antibody repertoire apply to this synthetic binder, thus demonstrating the robustness and
universality of our results.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).Introduction
Antibody molecules are able to recognize almost
any part of any antigen molecule [1]. This unique
property makes the antibody one of the most used
reagents in research, diagnosis, and therapy. As the
number of applications increases, along with the
demand for antibody improvements in affinity, spec-
ificity, stability, and solubility, so does the need to
refine the knowledge of antibody–antigen recognition
in greater details for enhanced rational designs.
The paratope is defined as the part of the antibody
that interacts with its target antigen. It is thus only
Author. Published by Elsevier Ltd. This
rg/licenses/by-nc-sa/3.0/).defined for a given antigen–antibody pair and is not a
per se entity [2]. As an example, some antibodies
have been shown to interact with different and
unrelated antigens and thus contain two different
paratopes [3,4]. However, there are some common
features in themode of binding that allow the paratope
to be partially defined independently of the antigen.
Antibody variable domains (Fv) can be divided into
hypervariable regions andmore conserved segments
called framework regions (FRs) [5,6]. Because most
of the diversity is located in the hypervariable regions
that pack together at the surface of the antibody and
make most of the contacts with the antigen, these
is an open access article under the CC BY-NC-SA license
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3730 Restricted Diversity of Antibody Paratope Residueshypervariable regions are usually considered to be
identical with the complementarity-determining re-
gions (CDR) that form the paratope. This is indeed
generally true since binding activity can be transferred
between antibody molecules by just exchanging their
hypervariable regions [7,8]. However, many residues
of the hypervariable regions never interact directly
with the antigen and only play a structural role [8,9],
and several residues located in FRs may also contact
the antigen [8,10]. Definition of the paratope is further
complicated by the importance of water molecules in
the stability of the binding complex [11].
An antibody and its antigen must possess a
complementary surface in terms of both shape and
chemical nature in order to achieve high affinity. The
shape diversity is mainly due not only to variations in
loop lengths and conformations [9,12–14] but also to
modifications in the relative orientation of heavy
chain variable domain (VH) and light chain variable
domain (VL) [15], as well as solvation of the binding
interface [11]. This shape complementarity involves
many aromatic residues that pull together the two
surfaces using mainly van der Waals and hydropho-
bic interactions [16]. Specificity and strengthening is
obtained by electrostatic interactions between
charged side chains, as well as hydrogen bonds
bridging oxygen and/or nitrogen atoms.
Several studies have analyzed large sets of
antibody–antigen complexes to precisely delineate
paratopes and epitopes. However, most of these
studies defined interacting residues by comparing
accessibility of the antibody residues in the presence
and in the absence of the bound antigen [13,17]. If a
residue is buried within the interacting interface, it is
considered as a contact residue and as participating
in the interaction. However, the change in solven-
t-accessible surface area does not always correlate
with the free energy of binding [18]. In other studies,
authors used a distance cutoff to define paratope
residues. For instance, in a series of papers, Dr.
Ofran's group identified interacting residues in 200
antibody–antigen complexes by considering that two
residues were in contact if they have at least one pair
of atoms within a distance of 6 Å from each other
[10,19,20]. Both approaches have the advantage of
giving an exhaustive list of potential paratope
residues at the expense of a large number of false
positive positions, since residues in direct contact
within the antibody–antigen interface do not neces-
sarily participate to the binding free energy [21].
In this work, we focused on a quantitative and
statistical analysis of side-chain contributions in a
large set of antibody–antigen complexes. We first
established a database of 227 non-redundant struc-
tures andwe calculated for each residue in the binding
interface its contribution to the antibody–antigen
interaction free energy using a computational alanine
scanning procedure. To compare the results between
structures, we numbered all antibodies using apreviously established numbering scheme that mini-
mizes the average deviation from the averaged
structure of the aligned domains [17]. This allowed
us to define quantitatively residue average contribu-
tions, revisit paratope definition, and address ques-
tions regarding the number of significant contacts, the
CDR relative free energy contributions, and side-
chain usage and roles. The study demonstrates that
paratopes are mainly discontinuous, comprise be-
tween 4 and 13 residues located within a set of 30
fixed positions, and contain a subset of amino acids
different from the one found at the rest of the antibody
surface. Finally, we solved the structure of an
antibody–antigen complex whose antibody had
been previously isolated from a biased synthetic
antibody repertoire with only two diversified CDRs,
and we demonstrated that this unnatural antibody
molecule fulfilled the rules obtained in our analysis
based on natural antibodies. Taken together, our
results reveal conserved structural constraints that
shape a restricted diversity of the antibody paratope,
being of natural or synthetic source, and should help
in the understanding of the mechanisms of immune
recognition and the rational design of new and
improved antibodies.Results
Aligned database of antibody side-chain binding
free energies to antigens
For the purpose of this study, we focused on
protein and peptide antigens since haptens are
known to have a different mode of binding that would
require an independent analysis to derive general
characteristic rules. We first recovered 506 struc-
tures of antibody–antigen complexes from the IMGT
database (Supplementary Table 1), removed mis--
annotated structures, and then filtered for sequence
redundancy. We independently extracted VH and
VL domains from the structures together with the
interacting molecules of the antigen. Finally, we
renamed antibody and antigen chains using a
common naming scheme and renumbered variable
domains using AHo numbering [17]. The choice of
AHo numbering was dictated by its design, based on
the spatial alignment of known three-dimensional
structures of immunoglobulin domains. The final
database contains 227VHand 206VL non-redundant
renumbered structures and their corresponding inter-
acting antigen molecules (Supplementary Table 2),
representing 206 Fv and 21 VHH. To evaluate the
contribution of each antibody side chain present in the
binding interface to the free energy of binding, we
performed computational alanine scanning experi-
ments using the FoldX program [22]. The contribution
of each residue side chain to the antibody–antigen
3731Restricted Diversity of Antibody Paratope Residuesbinding free energy for the 433 complexes is given in
Supplementary File complexes.xlsm.
Few residues contribute significantly to the
antibody–antigen binding free energy
For each structure, we ranked the residues in
decreasing order of their binding free energy and
computed the percentage of the binding free energy
obtained as a function of the number of residues for
the heavy chain (a), the light chain (b), and the
complete Fv domain (c) (Fig. 1). The side chain with
the highest antibody–antigen binding free energy
contributed on average to 22%, 33%, and 16% of the
ΔΔG for VH, VL, and Fv, respectively. As a general
trend, the free energy contribution decreased expo-
nentially with the ranking so that only the first few
residues contributed significantly to the binding free
energy. For instance, 80% of the binding free energy
was obtained with only 6 (IC95%: 2–10), 4 (IC95%:1 2 3 4 5 6 7 8 9 10
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Fig. 1. Number of residues participating in binding free energ
obtained for a given number of contact residues, for VH (a), VL
obtained for the GkF5 complex. Boxplot whiskers extend to the
interquartile range.1–6), and 8 (IC95%: 4–13) residues for the VH, VL,
and Fv, respectively. In other words, 80% of the
binding free energy is due to only 4–13 residues in
95% of the Fv–antigen complexes. Thus, this
represents the length of the functional paratope
formed by the residues that make energetically
favorable contacts with the antigen [23]. The result
was independent of the light chain class and the
number of contacts was identical for both λ and κ
variable domains (Supplementary Fig. 1). This
demonstrated that antibody paratopes require only
few residues of the CDRs to raise high affinity and
specificity.
Binding free energy per position
In the previous results, the considered residues
were different and optimally chosen for each
antibody–antigen complex. To determine if some
common residues were involved in the interaction,1 2 3 4 5 6 7
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3732 Restricted Diversity of Antibody Paratope Residueswe computed the mean binding free energy at each
position in the series of complexes. This was
possible thanks to the AHo numbering scheme
that insured that equally numbered residues were
also structural equivalents. Detailed results are
presented in Supplementary File complexes.xlsm.
A plot of the mean binding free energy per position is
shown in Fig. 2 for the heavy and light chains. Most
of the interacting sites were located in the CDR
regions (Kabat's definition) but some frequently
used positions such as H2, H29-32, H44, H54,
H108, H139, L2, L44, L54, and L57 were located in
the FRs (average ΔΔG N 0.1 kcal/mol). Within the
CDRs, there was an uneven distribution of the
antibody–antigen binding free energy limited to a
few specific positions (hot spots). Indeed only 2, 4, 1,
2, and 2 positions contributed to more than 60% of
the total CDR binding free energy for H1, H2, L1, L2,
and L3, respectively. We noticed that, only in H3, the
binding free energy was more evenly distributed.
This is due to the highly variable length of this CDR
that smoothes the energy per position. If the energy
distribution in H3 loops had been studied for any
given length, the distribution would have become
more heterogeneous, as for the other CDRsA
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Fig. 2. Average binding free energy. Bars represent the ave
for VL (top) and VH (bottom) domains. The bar color represents
of aligned antibody, from 0% (white) to 100% (deeper red).(Supplementary File complexes.xlsm). However,
because of the very high diversity of H3 loop
structures, the structural equivalence of equally
numbered residues is highly questionable, except
for the N- and C-terminal parts of the loops [24].
Positions were ranked according to their average Δ
ΔG, and the percentage of the total ΔΔG as a
function of the number of these fixed residues is
shown in Fig. 3. This showed, for example, that 80%
of the total ΔΔG localized among 30 positions, 27 in
the CDRs and 3 in FRs, for more than half of the
structures, representing only a fraction of the total
CDR positions (less than half of the CDR positions
according to Kabat's definition). Furthermore, sev-
eral of these positions were not always occupied
and their number could be easily reduced for most
antibodies. The results presented in Figs. 2 and 3
were obtained for the whole database that contains
mainly κ light chains. If analyzed independently, the
best positions were slightly dependent on the light
chain class, λ light chains having a stronger
propensity than κ light chains to bind the antigen
using residue L109 and κ light chains having
frequently longer L1 loops making contacts with
residues L32–L36 (Supplementary Fig. 2).Ho
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Fig. 3. Cumulative binding free energy. Distribution of the binding free energy for the 30 most contributing positions. The
energy is cumulative from the left. Only positions occupied in more than 40% of the structures are shown. Boxplot whiskers
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3733Restricted Diversity of Antibody Paratope ResiduesCDR contributions to antigen binding
The binding free energy contribution of each CDR
was computed for the 206 Fv–antigen complexes
(Fig. 4a). H2 and H3 were the two CDRs that
contributed the most to the antibody–antigen interac-
tion, each of them contributing to 22% of the total
binding free energy in half of the complexes. The three
CDRsH1, L1, and L3 contributed almost equally to the
free energy of interaction with a median value of 10%,
9%, and 12%, respectively. Finally, L2 did not interact
with the antigen in more than half of the complexes.
Furthermore, the number of CDRs involved in
antigen binding was estimated in each complex
(Fig. 4b). A CDR was considered as interacting with
the antigen when at least one of its residues
participated significantly in the interaction
(ΔΔG N 0.8 kcal/mol). The distribution of the number
of used CDRs showed that, in 97% of the cases, at
least three CDRs contained one or more such
important residues. It is noteworthy that the 206
complexes used in this analysis were all standard
antibodies with heavy and light chains, discarding
VHH-like antibodies for which the interaction mode,
constrained by only three CDRs was very different
(Supplementary Fig. 3).In correlation with the binding free energy contri-
bution of each CDR (Fig. 4a), H2 and H3 contained
at least one residue that contributed significantly to
the binding energy (ΔΔG N 0.8 kcal/mol) in 93% and
90% of the antibody–antigen complexes, respec-
tively, whereas only 39% of the structures showed a
significant interaction between L2 and the antigen
(Fig. 4c). Finally, H1, L1, and L3 contained a residue
with a significant free binding energy in 77%, 67%,
and 78% of the cases, respectively.
Side-chain usage and roles
Several studies have shown that particular amino
acid side chains play different roles during the
formation of a protein complex [25,26], including
antibodies [2,12,20,27–29]. Having identified the
antibody positions involved in antigen binding and
their average binding free energy, we focused on a
detailed analysis of the energy contributed by each
side-chain type during side chain–side chain inter-
actions. Paratope analysis was restricted to the 15
most contributing CDR positions that represented
about 50% of the binding energy (Fig. 3). As a
reference, we used 62 surface residues that never
interacted with the antigen (mean ΔG = 0 in Fig. 2
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Fig. 4. CDR contributions and usage. (a) Distribution of
the CDR binding free energy contributions. The value in
the boxes is the median of the distribution. Black-filled
triangles are the values obtained for the GkF5 complex.
Boxplot whiskers extend to the most extreme data point
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(b) Percentage of structure with a given number of
interacting CDR. (c) Percentage of structures in which
the indicated CDR contributes to the binding free energy.
3734 Restricted Diversity of Antibody Paratope Residuesand solvent accessibility N 19%). Side- chain usage
frequencies were very different for these two classes
of surface residues, illustrating a highly specificresidue usage at antibody hot spots (Fig. 5). Among
the 7 most frequent residues of these two groups,
representing 75% of the used residues, only two
residues were in common, G and S. Tyrosine, the
most frequent residue at hot spot positions with a
24% frequency, was only present with a 2.7%
frequency at non-paratope surface positions. This
general trend was found at most of the positions of
the paratope but H39, L40, and L137 showed a
somewhat different distribution, the two former being
strongly enriched in Tyr and the latter in Pro and Leu
(Supplementary Fig. 4).
We took advantage of the quantitative nature of
our database to also calculate the frequency of the
positive contributions of each residue of the para-
tope to the free energy of binding (black bars in
Fig. 5). The ranking of the residues was clearly
different and two classes could be identified:
residues that make frequent interactions with the
antigen, essentially aromatics, and neutral residues
that were frequently found in the paratope but did not
play any role in the binding free energy, as G and S.
Finally, for residues more frequently found at the
paratope than at other surface positions, we noticed
that their side chains made frequent interactions
with the antigen. For instance, Y andW, respectively
enriched 9 and 450 times, interacted with the
antigen 66% and 74% of the time, respectively,
and the other 3-fold enriched residues were also
involved in the stability of the complex at a frequency
of at least 25% (N: 25%, H: 37%, D: 31%, F: 32%).
On the other hand, residues Q, K, P, and T that were
3-fold less frequent in the paratope than on the
protein surface were also less likely to make
productive interactions with the antigen (Q: 22%,
K: 22%, T: 19%), except for proline (51% productive
interactions). This abnormal reduced frequency of
proline residues at hot spot positions is presumably
due to the structural constraint this amino acid would
impose on the CDR conformations when its pres-
ence is not required for shaping the paratope.
Universality of the characteristic rules, a structure
case study
Most of the antibodies present in the current
Protein Data Bank (PDB) and analyzed above have
been obtained from immunized animals and anti-
body phage libraries made from human donors. In
both cases, the diversity of the paratope is natural
and originates from V gene diversity, V(D)J recom-
bination and somatic hypermutation events. We
demonstrated that these antibodies interact with
their antigen using a very limited number of residues,
both in position and in nature. Such a restricted
diversity could originate from constraints imposed
either by the immune system or by the structure of
the antibody paratope itself. To address this ques-
tion, we isolated a single chain Fv (scFv) from a
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Fig. 5. Residue usage at paratope and non-paratope positions. The height of the bars is the frequency of a given
residue at the 15 most contribution positions of the paratope (left axis) or at 62 solvent-accessible and non-interacting
residues (right axis). The dark-gray bars are the frequency of the considered residue contributing to at least 0.8 kcal/mol to
the free energy of binding.
3735Restricted Diversity of Antibody Paratope Residuessynthetic strongly biased antibody library by panning
on Gankyrin antigen. This scFv binds its antigen with
a moderate affinity that has been estimated to 100–
200 nM using Biacore [30] and 450 nM by compe-
tition ELISA [31]. The complex is however stable
enough to be separated from the free antigen and
the scFv by gel-filtration chromatography [31]. In the
used library [32], diversity was introduced only in the
two CDR3s, the four other CDRs being fixed to those
of an anti-β-galactosidase antibody [33]. In addition,
whereas the introduced H3 sequence was close to a
human one, the introduced L3 was unnatural since
its N-terminal part did not correspond to any natural
germline. We then solved and analyzed the Gan-
kyrin–scFv F5 (GkF5) complex to determine whether
the library design may bias the paratope location and
chemical composition.
The crystal structure of the GkF5 was solved at
2.5 Å resolution (Table 1). The Gankyrin consists of
seven ankyrin repeats, ANK1–ANK7. Its conforma-
tion is similar to the previously solved Gankyrin
structures [34,35]. The Cα atoms of the bound and
the uncomplexed Gankyrin structures can be super-
imposed with a RMSD of 0.95 Å, showing no largeconformational rearrangements due to scFv binding.
The scFv F5 adopts the β-sheet-rich canonical
antibody fold but the glycine-rich linking region
between VH and VL chains was not seen in the
electron density map because of its flexibility. The
antibody F5 interacts with the α-helices of the ANK4–
ANK6 repeats, which are part of the convex face of
Gankyrin (Fig. 6a).
The antibody paratope is not limited to the two
diversified CDR3s but instead includes other CDRs
in contact with the antigen (Fig. 6a). Computational
alanine scanning analysis further specified that 12
antibody residues located in 5 CDRs and 1 FR were
implicated in the stability of the complex (Fig. 6b).
Eleven of these residues were located within the 30
best hot spot positions determined above from the
antibody–antigen database (Table 2 and Fig. 3) and
their binding free energy profiles fitted well with the
average values obtained in the database (filled
triangles in Fig. 1). The missed residue is N167
(L39) with a ΔΔG of 0.9 kcal/mol. This position has a
low average energy in the database due to its low
usage in κ light chains. However, if we only consider
Fv domains with a light chain of the same λ class
Table 1. Data collection and refinement statistics.
Gankyrin–F5 complex
Data processing
Resolution (Å) 30–2.5 (2.59–2.50)
Crystal space group P3221
Cell parameters (Å)
a 135.6
b 135.6
c 68.7
Unique reflections 25,162 (2438)
Mean redundancy 2.8 (2.7)
Rsym (%)
a 9.7 (45.4)
Completeness (%) 98.9 (97.9)
Mean I/σ 10.8 (2.2)
Wilson B-factor (Å2) 41.2
Refinement
Resolution (Å) 30–2.5
Number of non-hydrogen atoms
Gankyrin 1688
F5 antibody 1684
Water molecules 428
RMSD bond length (Å) 0.003
RMSD bond angles (°) 0.69
Rcryst (%)
b 16.4
Rfree (%)
c 20.8
Averaged B-factor for non-hydrogen atoms (Å2)
Gankyrin 26.6
Antibody F5 55.1
Water molecules 45.4
Ramachandran plot (%)
Core 87.5
Allowed 11.7
Generous 0.5
Disallowed 0.3
a Rsym = 100 × ∑hj|Ihj − 〈Ih〉|/∑hjIhj, where Ihj is the jth measure-
ment of the intensity of reflection h and 〈Ih〉 is its mean value.
b Rcryst = 100 × ∑||Fo| − |Fc||/∑|Fo|, where |Fo| and |Fc| are the
observed and calculated structure factor amplitudes, respectively.
c Calculated using a random set containing 5% of observations
that were not included throughout refinement [62].
3736 Restricted Diversity of Antibody Paratope Residuesthan the scFv F5, L39 ranks 18th with an average
ΔΔG of 0.6 kcal/mol (Supplementary Fig. 2). Fur-
thermore, the CDR contributions to the GkF5
complex were very similar to the averaged values
obtained from the database (filled triangle in Fig. 4a).
The binding free energy of the two diversified CDRs
(H3 and L3) added up to 32% of the total ΔΔG,
whereas the three interacting but fixed CDRs (H1,
H2, and L1) and the FRs contributed 68% to the total
ΔΔG. This higher contribution of the fixed part of the
paratope in the binding free energy is also found in
the number of contacts since the two CDR3s and the
non-diversified parts of the scFv (other CDRs and
FRs) formed 4 and 8 contacts with the antigen,
respectively. Finally, 83% of the total binding free
energy is due to only 8 residues as in natural
antibodies (Fig. 1c), 6 of them being Tyr.
To confirm this result using a different approach,
we determined antibody contacts using the Crystal-
lography and NMR System software suite that uses
geometric rules to identify interactions (Table 2)[36,37]. Ten of the twelve residues identified using
computational alanine scanning were also present in
this analysis, the two missed residues being Y34 and
Y185. In addition, among the 19 identified residues, 14
are in the list of the 30 most contributing positions
presented in Fig. 3. Altogether, this demonstrated
using two approaches that, despite its synthetic and
biased origin, scFv F5 paratope conforms well to the
general rules defined from our database analysis.
Universality of the characteristic rules, prediction
of important paratope residues
We next tested if our database can be used to
predict important paratope residues in the absence
of structural and experimental data. As a reference,
we used the experimental data generated by Muller
et al. [38] on a humanized anti-VEGF Fab. In this
publication, authors mutated one by one the 68 CDR
residues to alanine and measured the relative affinity
of the resulting mutant Fab. We grouped the CDR
residues in three categories: 8 major contributors
that affected the affinity by more than a 150-fold
factor, 11 residues decreasing the affinity by a more
moderate factor (between 5- and 66-fold), and 49
neutral or weak contributors. These residues are
displayed with dark green, light green, and white
backgrounds, respectively, in the line Muller1998 in
Fig. 7. If we compare the location of these residues
with the positions identified as the main hot spots in
our study (Fig. 2), 7 of the 8 Muller's major
contributors have an average binding free energy
higher than 0.8 kcal/mol. Since only 12 hot spot
positions have such a high average binding free
energy, this means that using our data and targeting
mutations to these 12 residues would have identified
7 (88%) out of 8 of the Fab major paratope residues.
If we decrease the binding free energy cutoff value to
0.4 kcal/mol, our database identified 27 potential
interaction sites in the Fab paratope (red and pink
backgrounds in Fig. 7). Among these 27 sites, 15
positions were also identified (moderate or major
contributors) in Muller's data. In that case, experi-
mental alanine scanning of only 27 positions would
have identified 15 (79%) out of 19 of the paratope
residues. This good correlation between the identi-
fied positions and the experimental data was further
confirmed using a second antibody for which the
whole CDRs were also analyzed using shotgun
scanning mutagenesis [23]. Again, among the 12
positions with an average binding free energy higher
than 0.8 kcal/mol, all but two had a strong deleteri-
ous effect (Fwt/ala N 20) when mutated to alanine
(Supplementary Fig. 5). Both of the two positions
with a high energy that did not affect binding were in
the light chain (L40 and L137) that marginally
participates to the interaction in this particular anti-
body. In addition, only 2 of the 12 positions affecting
the binding by more than a 50-fold factor have an
(a) (b)
(c) (d)
VL
VH
CDR3 CDR3
CDR1CDR2
CDR2CDR1
Gk
Fig. 6. GkF5 structure and analysis. (a) Overall view of the GkF5 complex. Each ankyrin repeat of Gankyrin is indicated
by ANK1–ANK7 and different colors (from blue to red). The VH and VL domains of the antibody F5 are colored cyan and
magenta, respectively. Dotted line represents unstructured linking region of the antibody. (b) GkF5 paratope. The 12
interacting residue side chains identified by computational alanine scanning (Table 2) are represented. The six CDRs are
colored orange (H1), pink (H2), yellow (H3), green (L1), purple (L2), and red (L3). Ionic and hydrogen bonds between scFv
F5 and Gankyrin are represented in the vicinity of the VL (c) and the VH (d) domains (Table 2). VL, VH, ANK4, ANK5, and
ANK6 repeats are colored magenta, cyan, yellow, orange, and brown, respectively. Oxygen and nitrogen atoms are
colored red and blue, respectively. Red and black dotted lines indicate ionic and hydrogen bonds, respectively.
3737Restricted Diversity of Antibody Paratope Residuesaverage binding energy lower than 0.4 kcal/mol in our
database (H33 and H135).
This demonstrated that our compiled database of
free binding energy can be used to pinpoint important
residues in an antibody paratope, decrease the
number of residues to be experimentally tested by
site-directed mutagenesis, and increase the chances
to identify quickly the critical binding residues.Discussion
The aim of this study was to describe quantitatively
at the molecular level the mode of binding of
antibody molecules to their cognate antigens,
identify the critical residues of the paratope both in
position and in nature, and derive general rules to
help in antibody engineering and library design.
Large-scale alanine scanning analysis on an aligned
non-redundant structural database of antibody–
antigen complexes enabled the first quantitative
description of the role of all the antibody residues in
the free energy of binding. These data provide aquantitative description of paratopes from which
characteristic rules can be derived. (1) Eighty percent
of the binding energy is due to only a few significant
residues, typically 8 (between 4 and 13). (2) These
residues localize among 25–30 fixed hot spot
positions that contribute to 75–80% of the energy in
more than half of the complexes. (3) Between 3 and 6
CDRs are involved in the complex formation. (4) Hot
spot positions are occupied by a restricted number of
side chains (Y, G, S,W,D, andN in 61%of the cases),
(5) among which essentially aromatic residues con-
tribute to the binding free energy. These rules are valid
not only for natural antibodies that constitute the
majority of the structures used in this analysis but also
to a synthetic antibody selected from a highly biased
library with a focused and restricted diversity, and
thus, these represent constraints present in most
antibody–antigen complexes.
It is known since the first solved antibody–antigen
structure that only a small subset of contact residues
dominates the energetics of the association reaction.
Several antibody–antigen complexes have been
studied using experimental alanine scanning
Table 2. F5 hot spot positions and GkF5 contacts.
Ranka AHo CDR scFv F5b ΔΔGc Interactiond Gankyrine
1 L40 L1 Y168 3.2 VDW ANK5:L152/K153/H156
2 H40 H1 S35 1.0 H-bond ANK4:E127 ANK5:Y160
3 H59 H2 S54 VDW ANK4:E127
6 H39 H1 Y34 0.9
7 H112 H3 D104 Ionic bond ANK5:K153
9 L57 FR Y185 3.1
10 H111 H3 I103 2.4 VDW ANK5:K153/H156/I157/Y160
12 H69 H2 Y61 3.1 H-bond ANK5:Y160
VDW ANK5:K162
13 L109 L3 Y227 2.3 VDW ANK5:H156
16 H110 H3 V102 1.9 VDW ANK5:Y160
17 L58 L2 E186 Ionic bond ANK5:K153
18 L33 L1 G165 VDW ANK6:E186
19 H60 H2 G55 H-bond ANK4:E127
20 L110 L3 I228 1.5 VDW ANK5:H156
24 H67 H2 Y59 2.7 VDW ANK5:Y161/K162
27*f L38 L1 Y166 2.0 H-bond ANK5:H156
VDW ANK5:L152 ANK6:E186/K189/L190/S193
32*f L112 L3 S230 VDW ANK5:Y160
34 L111 L3 S229 VDW ANK6:Q194
41 H33 H1 N33 VDW ANK4:E127
42 L39 L1 N167 0.9 VDW ANK5:H156
54 H30 FR T30 VDW ANK3:K90
a Rank of the residue as defined in Fig. 3.
b Nature of the residue in scFv F5. Numbering scheme is the sequential numbering used in the PDB ID: 4NIK structure. Equivalence
between the different numbering schemes is given in Supplementary Table 3.
c ΔΔG of the residue in the scFv F5–Gankyrin complex, determined by computational alanine scanning, in kilocalories per mole. Only
ΔΔG N 0.8 kcal/mol are shown.
d Type of contact.
e Interacting residue in Gankyrin determined using contact.inp command in CNS. ANKn is the ankyrin repeat to which the following
residue belongs.
f Position occupied in less than 40% of the antibody sequences and excluded from the ranking in Fig. 3. The rank given is that of the
residue with the closest ΔΔG and present in more than 40% of the sequences.
3738 Restricted Diversity of Antibody Paratope Residuesmutagenesis and the effects precisely quantified.
With the use of different models, it has been shown
that the interaction involves between 5 and 10 main
residue contributors [3,21]. Even in the case of an
antibody with a very high affinity of 50 pM for its
antigen, only 4–5 residues of the light chain
contributed significantly to the binding energy [39],
in good agreement with the values obtained from our
database (Fig. 1b). Some known antibodies deviate
however from this general rule as the anti-idiotypic
antibody E5.2 in which most of the contact residues
play a significant role in the binding free energy
[3,40]. This discontinuous nature of the paratope
may play a functional role since it makes the
antibody more tolerant to mutations of the antigen,
particularly because a loss of contact can be
compensated by new water molecules, as demon-
strated in the case of HEL D18A mutants in
interaction with D1.3 antibody [40]. However, the
novelty of our study is to show that there is a
common mode of binding for almost all the antibody
molecules present in the PDB. In other words, not
only few residues contribute to the binding free
energy but also these residues are mainly located at
about 25 conserved positions. This restricted num-
ber of paratope residues may explain why D1.3bound with the lysozyme and the anti-idiotypic
antibody D5.2 showed a similar mode of binding
with 13 common hot spot residues among 17
contacts [41]. Again, in some special cases, anti-
bodies may adapt their binding in an unconventional
manner as demonstrated in some highly mutated
cross-neutralizing anti-human immunodeficiency
virus antibodies [42].
Several studies have analyzed the distribution of
side chains in the paratope of antibody molecules
and concluded that there is notably a strong bias
toward some aromatic residues [2,12,20,27–29].
However, in these analyses, authors used a defini-
tion of the paratope that spanned most of the CDR
residues. For instance, Collis et al. analyzed the
amino acid distribution at positions [12] they previ-
ously defined as contact residues [13]. Though being
shorter than classical CDRs, these regions are still
large and contain more than 50 residues. In our
case, we restricted the analysis to the positions that
formed an energetically favorable contact with the
antigen in most of the analyzed structures since we
only considered the 15 positions with the highest
average free binding energy (ΔΔG N 0.87 kcal/mol).
In addition, we used surface residues of antibody
molecules as a reference whereas Collis used loop
L1                   AHo 24 25 26 … 29 30 31 32 … 39 40 41 42
VL mean ΔΔG 0.00 0.00 0.00 0.05 0.05 0.09 0.18 0.18 1.73 0.00 0.27
aa hot propensity 0.07 0.00 0.07 0.22 0.31 0.59 0.07 0.25 0.66 0.58 0.25
VL anti-VEGF S A S Q D I S N Y L N
Muller1998 1.3 1.1 1.5 1.2 1.2 1.4 1.5 1.7 1.9 2.2 3.7
L2                   AHo 58 … 67 68 69 70 71 72
VL mean ΔΔG 0.66 0.06 0.04 0.22 0.07 0.14 0.07
aa hot propensity 0.62 0.19 0.07 0.07 0.58 0.37 0.07
VL anti-VEGF F T S S L H S
Muller1998 1.40 0.78 0.75 0.76 0.86 0.98 0.85
L3                   AHo 107 108 109 110 111 … 135 136 137 138
VL mean ΔΔG 0.19 0.10 0.96 0.66 0.33 0.59 0.19 0.81 0.00
aa hot propensity 0.22 0.22 0.66 0.07 0.19 0.33 0.51 0.74 0.19
VL anti-VEGF Q Q Y S T V P W T
Muller1998 3.7 2.7 14 0.90 0.87 1.5 3.5 150 1.4
H1                   AHo 27 28 29 30 31 32 33 … 39 40 41 42
VH mean ΔΔG 0.00 0.45 0.10 0.10 0.13 0.24 0.99 1.54 0.01 0.54
aa hot propensity 0.00 0.66 0.19 0.62 0.19 0.25 0.66 0.00 0.27 0.25
VH anti-VEGF G Y T F T N Y G M N
Muller1998 2.3 34 1.3 16 1.3 150 150 6.1 6.3 66
H2                   AHo 57 58 59 60 61 … 65 66 67 68 69 70 71 72 73 74 75 76
VH mean ΔΔG 1.34 0.19 1.67 0.66 0.50 0.59 0.03 0.65 0.14 0.91 0.24 0.02 0.03 0.01 0.00 0.03 0.00
aa hot propensity 0.74 0.59 0.25 0.19 0.66 0.19 0.00 0.34 0.51 0.19 0.66 0.00 0.00 0.31 0.62 0.22 0.45
VH anti-VEGF W I N T Y T G E P T Y A A D F K R
Muller1998 150 3.8 150 8.6 8.7 4.4 1.1 1.7 1.5 2.6 2.0 1.2 1.4 1.4 0.97 1.2 1.2
H3                   AHo 109 110 111 112 113 114 115 … 132 133 134 135 136 137 138
VH mean ΔΔG 0.96 0.71 0.97 1.02 0.79 0.61 0.61 0.84 0.51 1.03 0.31 0.40 0.26 0.29
aa hot propensity 0.66 0.51 0.37 0.66 0.66 0.00 0.07 0.07 0.37 0.74 0.66 0.62 0.31 0.33
VH anti-VEGF Y P H Y Y G S S H W Y F D V
Muller1998 150 38 4.1 3.8 4.8 1.8 0.7 150 2.4 150 19 25 1.9 1.3
Fig. 7. Analysis of an anti-VEGF paratope. Data were generated using the spreadsheet “complexes.xlsm” supplied as
Supplementary Material. The six regions corresponding to the six CDRs and mutagenized in Muller's publication [38] are
shown. First line: AHo numbering. A black background indicates Kabat's CDRs. VH mean ΔΔG: average binding free
energy (Fig. 2). Positions with a ΔΔG N 0.8 and 0.4 kcal/mol are in red and pink, respectively. aa hot propensity: for the
considered amino acid, this is the frequency at which this side chain makes an energetically favorable bond at the 15
strongest hot spot positions (Fig. 5). VH/VL anti-VEGF: sequence of the anti-VEGF Fab-12. Muller1998: fold change of the
binding affinity when the position is mutated to alanine in Muller's publication. Main paratope residues (150-fold decrease
in affinity) are in dark green and moderate contributors (between 5- and 66-fold) are in light green.
3739Restricted Diversity of Antibody Paratope Residuesregions from the CATH database. Despite these
differences, we share the main observation that Tyr
and Trp are strongly enriched in the paratope of
antibodies. However, this enrichment is larger in our
case presumably because of the prominent role of
these residues in the free energy of binding. There
are also subtle discordances that may be due to the
different sets of residues analyzed. We noted an
enrichment of the two other aromatic residues (F and
H), Asp, and Asn whereas Collis did not see any
significant enrichment of these amino acids in the
paratope. As for Tyr and Trp, this discrepancy could
be attributed to the important contribution to the free
binding energy of these side chains in our analysis.
The discontinuous nature of the paratope presented
here is different from the classical CDR definition.
Indeed, most of the main contributing residues are
part of Kabat's hypervariable regions but the reverse
is not true, since only 25% of these regions contribute
to more than 70% of the binding free energy.
However, many of the non-interacting residues play
an important structural role in avoiding steric clashes
and in shaping the paratope [9,13]. The importance of
these residues in the antigen binding affinity has been
demonstrated in several studies. However, they did
not show up in our analysis for two main reasons.
First, the used FoldX script restrained the analysis to
the residues present in the interface between theantibody and the antigen. Second, the importance of
these residues is highly variable between antibody
molecules and we averaged the energy on the whole
database of 227 structures. Such regions are clearly
visible in Fig. 2 as, for example, framework positions
H82–H84 but their contributions are restricted to few
antibodies. Nevertheless, our study shows that the
interacting residues remain broadly conserved, pro-
vided that a proper numbering of the loops is used.
The important positions identified heremay help in the
design of several experiments, as antibody–antigen
modeling and docking, affinity maturation, paratope
identification, CDR and SDR grafting [43], and library
design. Restraining diversity to the identified positions
and using a genetic code focused toward the most
important side chains should allow the construction of
smaller yet efficient antibody libraries, as already
demonstrated in a series of papers by Dr. Sidhu
[29,44,45].
As a direct application, we show that our data may
be used to quickly pinpoint important residues in an
antibody paratope. This can be then experimentally
confirmed but with only few mutations. For instance,
as shown in Fig. 7 in the case of an anti-VEGF Fab, 7
of the 8 most important residues of the paratope
could have been identified using only 12 mutations
and an almost complete description of the paratope
would have been obtained by testing only 27 positions
3740 Restricted Diversity of Antibody Paratope Residuesinstead of the 68 mutations necessary to cover the
six CDRs (Supplementary Fig. 6). This information
could be subsequently used to evolve an antibody
for better affinity using different techniques or
assumptions. For instance, the identified positions
could be targeted first for optimization using
mutagenesis and selection or, on the opposite,
these positions can be kept unchanged and only
surrounding residues mutagenized [46–49]. A
spreadsheet is available as a supplementary mate-
rial (complexes.xlsm) to help the reader in aligning
his own antibody sequence with our data.
Many of the results presented here are dependent
on the numbering scheme used. The relative
benefits of the different schemes have been
discussed elsewhere [50] and we decided to use
the AHo scheme [17] for two main reasons. First,
length variations in CDR1 are accommodated with
two gaps, separated by the conserved hydrophobic
residue 31. Second, insertions and deletions are
placed symmetrically around a key position (marked
in yellow in Supplementary File complexes.xlsm),
whereas in the other numbering schemes, inser-
tions are growing unidirectionally. These modifica-
tions result in a better alignment of the loops and
ensure that structurally equivalent residues are
identically numbered not only in the FRs but also
in the CDRs. However, long loops provide more
potential interaction sites. This is indicated in Fig. 2
by the white bars that represent hot spots only
present in long CDRs. These positions are located
at the top of the loops and are more frequent in the L1
and H3 CDRs. Nevertheless, these contacts present
in the longest loops usually add to but not substitute for
the other contacts present in the shorter loops,
resulting in a stronger interaction of the considered
CDR with the antigen. The case of the VH CDR3 is
presumably somewhat different because of the very
high diversity of H3 loop structures [24], but however,
some positions seem to be preferentially used in
certain loop lengths (Supplementary Fi le
complexes.xlsm).
A trend in the selection of binders and library
design is to expand the natural diversity to alleviate
innate binding restrictions. This has been one of the
main arguments in favor of synthetic and semisyn-
thetic antibody libraries over natural ones to derive
antibodies against self-proteins. However, there is
no experimental evidence showing that such syn-
thetic libraries are indeed more capable of generat-
ing such binders than natural repertoires, and
several anti-self antibodies have been successfully
selected from libraries made from human donors.
We directly tested the possibility of escaping the
natural antibody mode of binding by selecting an
scFv from a synthetic and strongly biased library and
solving the structure of the complex. Contrary to
usual expectations, most of the binding free energy
(68%) is due to non-diversified positions. Theantibody almost perfectly fulfilled the rules defined
above since most of the interacting residues were
located at the hot spot positions identified in this
study, and the CDR contributions were similar to the
averaged values obtained from the database. In a
recent study, Persson et al. isolated a series of 10
clones sharing the same H3 sequence despite
interacting with different antigens [51]. As in our
case, they showed that, in 80% of these clones,
several conserved invariant H3 side chains inter-
acted with the antigen. They also isolated two
antibodies in which the H3 loop was not involved in
the interaction with the antigen, in good agreement
with the frequency of 10% of such antibodies in our
database (Fig. 4c). The main conclusion of their
study is that antibody libraries can be designed to
give a dominant role to the L3 loop. Although this
remains true but taken individually, such antibodies
exist in nature. Indeed, as shown in Fig. 4a, in some
antibody–antigen complexes, the L3 loop contrib-
utes to more than 40% of the binding energy. This
shows again that the described rules are due to
antibody and antigen structural constraints and
cannot be easily escaped even with highly biased
and unnatural libraries.
In summary, our results demonstrate the parsi-
monious approach followed by nature to introduce
diversity in antibody paratopes. Restraining the
diversity to key positions and using a restricted set
of side chains are presumably required since the
immune system cannot sample the large number of
potential diversity represented by random
sequences in the six CDRs (about 2060–1078).
However, we showed that this is also true in the case
of a synthetic antibody repertoire. Our analysis adds
to the understanding of antibody–antigen interac-
tions and may help the future design of improved
antibodies and libraries with optimized functional
diversities.Materials and MethodsGenerating the set of antibody–antigen complexes
The structures of the antibody/antigen complexes from
the PDB were retrieved from the IMGT/3Dstructure-DB
database (IMGT®, the international ImMunoGeneTics
information system®†) [52]. A total of 506 PDB files of
immunoglobulin antibody or antibody fragments in com-
plex either with protein or with peptide ligands were
retrieved from the database (data from May 2011). We
extracted 484 VH, 404 VL-κ, and 59 VL-λ sequences from
these files. The difference between the number of PDB
files and antibody sequences extracted is due to files
containing Fc domains only (lacking variable chains),
which we removed from the set. VH sequences were
clustered using program cd-hit [53] with default parame-
ters and a 92% identity cutoff value, and the sequence
3741Restricted Diversity of Antibody Paratope Residueswith the best resolution was kept in each cluster, resulting
in 238 VH, 183 VL-κ, and 30 VL-λ. All files were
renumbered using AHo numbering scheme [17] that
minimizes the average deviation of residues in aligned
three-dimensional structures of immunoglobulin domains,
using a set of already aligned variable domains present in
the original publication [17], clustalw software, and
in-house python scripts. Unconventional sequences that
were incompatible with AHo numbering were discarded
resulting in 234 VH, 183 VL-κ, and 30 VL-λ sequences.
When multiple molecules were present in the crystal
asymmetric unit, only a single copy of the variable domain
was kept and renamed “H”, “L”, or “K” for VH, VL-λ, and
VL-κ, respectively (in-house python script). Ligand inter-
acting chains were defined as possessing at least one
contact with antibody CDR residues using NCONT
program from CCP4 suite [54]. Structures devoid of any
ligand chain interacting with the variable domains were
discarded. Inspection of these particular files showed that
either the ligands were haptens mis-annotated as peptide
in the IMGT (thus ignored by NCONT) or the interaction
was through the Fc domain. The final antibody–antigen
database consisted of 227 VH, 175 VL-κ, and 31 VL-λ,
including the structure solved in this study.
Binding free energy calculations using FoldX
Prior to change in binding free energy calculations, all
complexes were optimized using the repair function of
FoldX 3.0beta6 [22]. Following optimization of the
complexes, we computed the free energies of each of
the antibody side chains contributing to the antibody–
antigen interactions using the Complex_alascan com-
mand of the FoldX program, whereby each position
(except glycine and alanine) of a given antibody–antigen
interface was truncated to alanine and the positions of the
neighboring side chains were optimized. The result
provided was the difference in binding free energy ΔΔG,
in kilocalories per mole, between the “mutant” and the
“wild-type” structures, corresponding to the binding free
energy of each of the antibody side chain present in the
interface and contributing to the antibody–antigen inter-
action (intermolecular bonds).Data collection, structuredetermination, and refinement
The proteins were expressed and purified as previously
described [31]. Crystals of the complexes of Gankyrin and
scFv F5 were obtained at 17 °C by vapor diffusion in
sitting drops by mixing 0.2 μl of the protein solution and
0.2 μl of reservoir solution containing 0.1 M Hepes
(pH 7.0) and 8% polyethylene glycol 8000. The crystal
was mounted in a fiber loop and flash-cooled in liquid
nitrogen after cryoprotection with the reservoir solution
plus 15% ethylene glycol. Data collection from a frozen
single crystal was performed at 100 K on the beamline
ID29 of the European Synchrotron Radiation Facility
(Grenoble, France). The crystal belongs to the trigonal
space group P3221, with one Gankyrin–scFv F5 complex
per asymmetric unit. The data were integrated and scaled
using HKL2000 [55] (see statistics in Table 1). The
structures were solved by molecular replacement using
the program AMoRe [56]. The structure of Gankyrin and aneutralizing antibody F10 [PDB ID: 1UOH and PDB ID:
3FKU (chain X), respectively] were used as starting models
[34,57]. Refinement involved iterative cycles of manual
building and refinement calculations. The programs phe-
nix.refine [58] and Coot [59] were used throughout structure
determination and refinement. Several terminal residues
and 16 residues (119–134) of the linker of the scFv F5 are
not modeled as electron density map was poor in the
corresponding regions. Anisotropic scaling, a bulk solvent
correction, and TLS restrains were used. Five TLS groups
for Gankyrin and four groups for scFv F5 were generated by
using the program TLSMD [60]. Individual B atomic factors
were refined isotropically. Solvent molecules were then
placed according to unassigned peaks in the electron
density map. In the Gankyrin–scFv F5 complex, refined at
2.5 Å with no σ cutoff, the final model contains 224 residues
(3–226) for Gankyrin, 225 residues (3–119 and 134–244) for
antibody scFv F5, and 428 water molecules. Free R value
was calculated as described previously [61]. Structural
figures were generated by using the program PyMOL [62].
Accession numbers
The Worldwide PDB accession number of the scFv F5–
Gankyrin structure is PDB ID: 4NIK.Acknowledgments
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